Ignite Creation Date:
2025-12-24 @ 10:53 PM
Ignite Modification Date:
2026-01-25 @ 3:10 AM
Study NCT ID:
NCT00057369
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2003-03-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections
Sponsor:
Vicuron Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Bacteremia | View |
Keywords: